Mass General Hospital, Est. 1811

Depression Clinical
and Research Program

  • Home
  • Clinical Care
  • Depression Information
    • About Depression
    • Alternate Treatments
      for Depression
    • Psychiatry in
      Primary Care
    • menu bottom image
  • Publications
    • Alternative Treatments for Depression
    • Treatment Resistant Depression
    • Major Depression and Other Disorders
    • Medication Side Effects
    • Minor Depression
    • Treatments for Depression
    • Psychotic Depression
    • Hormone/Biological/Genetic Research on Depression
    • menu bottom image
  • Current Studies
    • Dual Diagnoses Studies
    • Studies for depressed patients not taking any antidepressants
    • Studies for depressed patients currently taking antidepressants
    • Non-treatment Studies
    • Studies for Smoking Cessation & Relapse Prevention
    • Other Studies
    • Psychotherapy Studies
    • menu bottom image
  • Links
  • Staff
    • Director
    • Associate Directors
    • Psychiatrists
    • Psychologists
    • Administrative Staff
    • Program Coordinator
    • Research Coordinators
    • Previous Staff
    • menu bottom image
  • Funding
    • The Goldstein Fund
    • The Judith Brown Caro Fund
    • Donations
    • menu bottom image
  • Contact
  • All Current Studies
  • Dual Diagnoses Studies
  • Studies for depressed patients not taking any antidepressants
  • Studies for depressed patients currently taking antidepressants
  • Non-treatment studies
  • Studies for Smoking Cessation & Relapse Prevention
  • Other Studies
  • Psychotherapy Studies
    • QEEG Predictors of Response for Psychotherapy Compared to Pharmacotherapy in Depression
    • Neural Correlates of Psychodynamic Psychotherapy for Depression
    • Psychosocial treatment of Depressive disorders in Parkinson's Disease
    • Stress Reduction Intervention for Depressed Minority Patients

QEEG Predictors of Response for Psychotherapy Compared to Pharmacotherapy in Depression

The purpose of this research study is to find out if a test can predict whether someone with depression will get better with treatment. We also want to find out whether there are changes in the brains of depressed patients having different types of treatment (drug therapy vs. talk therapy). We hope that a test called QEEG (Quantitative Electroencephalogram) can tell us if a treatment is going to work, even before the person starts to feel better. QEEG is a painless test that measures the electrical activity of the brain.

In this study, we will compare treatment with a talk therapy called Cognitive Behavioral Therapy (CBT) to a treatment with a medication called escitalopram, or Lexapro. All subjects in this study will receive active treatment, and will be assigned by chance like the flip of a coin to either CBT or Lexapro. If you are assigned to receive CBT, you will come in for a 50-minute therapy session once each week for 12 weeks, and if you are assigned to receive Lexapro, a study doctor will see you for a 30-minute appointment every 2 weeks. Both groups will be asked to perform QEEG at five of the study visits.

If interested, please contact Jessica Sousa at jsousa2@partners.org or at 617-726-0517.


We initiate new studies regularly, so please contact us for additional information.

© 2008 The Depression Clinical and Research Program at Massachusetts General Hospital
50 Staniford Street, 4th Floor | Boston, MA 02114 | 1-877-552-5837

Directions